Raylene Dyson

Q: What is Raylene Dyson email address?

Email Raylene Dyson at raylenedyson@gmail.com and raylene.dyson@novartis.com. This email is the most updated Raylene Dyson's email found in 2026.

Q: How to contact Raylene Dyson?

To contact Raylene Dyson send an email to raylenedyson@gmail.com or raylene.dyson@novartis.com. (updated on August 16, 2025)

RA CMC Director at Novartis | Basel Metropolitan Area

About Raylene Dyson

Raylene Dyson currently serves as the RA CMC Director at Novartis, where she plays a pivotal role in shaping the regulatory strategy for small molecule products within the cardiovascular, metabolic, and renal therapeutic areas. Her leadership is instrumental in guiding complex CMC (Chemistry, Manufacturing, and Controls) activities through both registration and post-approval phases, ensuring compliance with global regulatory standards while supporting the company's innovative pipeline. Raylene's expertise encompasses the assessment, review, and authoring of high-quality regulatory CMC documentation, which is critical for seamless submissions across diverse markets and regulatory jurisdictions. Her strategic approach emphasizes collaboration with cross-functional teams—including manufacturing, quality, and clinical development—to facilitate technology transfers, change controls, and continuous process improvements that align with Novartis’ commitment to patient safety and product quality.

With over two decades of experience, Raylene is deeply passionate about talent development and fostering a culture of excellence within her teams. She actively mentors emerging regulatory professionals, encouraging interdisciplinary collaboration and continuous learning to meet the evolving demands of the pharmaceutical industry. Her hands-on involvement in key projects—such as lifecycle management initiatives, regulatory filings for new formulations, and post-approval change management—demonstrates her ability to navigate complex regulatory landscapes while maintaining agility and strategic focus. Raylene’s dedication to advancing regulatory science and her proactive leadership in change control and technology transfer initiatives position her as a driving force behind Novartis’ success in delivering innovative therapies to patients worldwide.

Raylene Dyson Work